Personalis is a pioneering company based in Fremont, California, dedicated to transforming cancer management through innovative personalized testing. By leveraging highly sensitive assays that combine tumor and normal profiling with proprietary algorithms, Personalis provides advanced insights into cancer evolution, enabling early detection of minimal residual disease (MRD) and recurrence. The company focuses on guiding patient care throughout the cancer journey and supports targeted therapy selection through ultra-comprehensive genomic profiling. With a commitment to precision oncology, Personalis is positioned as a leader in the field, driving awareness and demand for its BioPharma portfolio.